We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The High Commissioner was provided with a tour of the vaccine fill-finish facility which is currently contracted by the UK Government to manufacture the Oxford/AstraZeneca COVID-19 vaccine until August 2022.